Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vincent Sunder-Plassmann"'
Autor:
Isolde Sommer, Vincent Sunder-Plassmann, Piotr Ratajczak, Robert Emprechtinger, Andreea Dobrescu, Ursula Griebler, Gerald Gartlehner
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract There is concern that preprint articles will lead to an increase in the amount of scientifically invalid work available. The objectives of this study were to determine the proportion of prevention preprints published within 12 months, the co
Externí odkaz:
https://doaj.org/article/b0594bed71a149f287dea18d23841022
Autor:
Vincent Sunder-Plassmann, Osman Aksoy, Judith Lind, Martin Pecherstorfer, Sonia Vallet, Klaus Podar
Publikováno v:
Expert Opinion on Pharmacotherapy. 23:1425-1444
The pace at which the identification of novel therapeutic targets has led to the approval of multiple myeloma (MM) agents during the last two decades is nothing more than spectacular. Nevertheless, MM remains an incurable disease. Therefore, there is
Autor:
Tamara Gassner, Sonia Vallet, Christina Chittilappilly, Theo Pirich, Judith Lind, Osman Aksoy, Vincent Sunder-Plassmann, Klaus Hackner, Elisabeth Zwickl-Traxler, Peter Errhalt, Martin Pecherstorfer, Klaus Podar
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Cytokine. 161
In Multiple Myeloma (MM) the finely tuned homeostasis of the bone marrow (BM) microenvironment is disrupted. Evasion of programmed cell death (apoptosis) represents a hallmark of cancer. Besides genetic aberrations, the supportive and protective MM B
Autor:
Judith Lind, Vincent Sunder-Plassmann, Martin Pecherstorfer, Osman Aksoy, Sonia Vallet, Klaus Podar
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S83-S84
Background Despite major advances in multiple myeloma (MM) therapy over the last 2 decades, most patients relapse. The identification of novel targets and development of derived treatment approaches are therefore urgently needed. Aberrant expression
Autor:
Osman Aksoy, Erwin F. Wagner, Fengjuan Fan, Latifa Bakiri, Judith Lind, Martin Pecherstorfer, Martin Sattler, Sonia Vallet, Vincent Sunder-Plassmann, Klaus Podar, Karoline Kollmann, Dagmar Stoiber-Sakaguchi, Elisabeth Zwickl-Traxler
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S19-S20
Background Transcription factors (TF) are convergence points of signaling cascades that coordinate cell differentiation, proliferation and survival and are commonly deregulated in cancer, including multiple myeloma (MM). They contribute to the initia
Autor:
Judith Lind, Sonia Vallet, Karoline Kollmann, Osman Aksoy, Vincent Sunder-Plassmann, Fengjuan Fan, Elisabeth Zwickl-Traxler, Dagmar Stoiber, Latifa Bakiri, Erwin F Wagner, Martin Sattler, Martin Percherstorfer, Klaus Podar
Publikováno v:
Blood. 138:2644-2644
INTRODUCTION Transcription factors (TFs) are convergence points of signaling cascades that coordinate cell differentiation, proliferation and survival and are commonly deregulated in cancer, including multiple myeloma (MM). They contribute to the ini